International Vaccine Institute

International Vaccine Institute is a research organisation in Seoul, South Korea that has taken part in 8 EU-funded projects since 2009, receiving €8.9M in EU funding.

EU funding received€8.9M
EU projects8
As coordinator0
Running now4
First EU project2009
Latest project2026
CountrySouth Korea
EU registration (PIC)997907386
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are International Vaccine Institute's own share of each project, not the project's full budget.

  • Horizon Europe€7.3M · 3 projects
  • Horizon 2020€1.5M · 2 projects
  • FP7 (2007 to 2013)€160k · 2 projects
  • Erasmus+ (ERASMUS+)€0 · 1 project

Projects

8 EU-funded projects, newest first. Each links to the official record.

  • DENSTARPartner

    Dengue Efficacy & Safety Trial in African Region

    Horizon Europe · 2026–2030 · Project on CORDIS ↗

    €2.2Mtheir share
  • ACT-CHIKPartner

    Accelerating Clinical Trials for CHIKungunya Vaccine in Africa

    Horizon Europe · 2026–2030 · Project on CORDIS ↗

    €4.9Mtheir share
  • LIVE_InnovAssociated partner

    Leading International Vaccinology Education for Innovation

    Erasmus+ (ERASMUS+) · 2024–2030 · Project on the EU portal ↗

  • CCHFVACIMPartner

    Crimean-Congo Haemorrhagic Fever Vaccine and Immunotherapy

    Horizon Europe · 2024–2027 · Project on CORDIS ↗

    €185ktheir share
  • VASAPartner

    Vaccine Against Schistosomiasis for Africa. A Phase I clinical study of the SchistoShield® anti-schistosomiasis vaccine in adults in endemic areas of sub-Saharan Africa

    Horizon 2020 · 2019–2026 · Project on CORDIS ↗

    €1.5Mtheir share
  • ZikaPLANPartner

    Zika Preparedness Latin American Network

    Horizon 2020 · 2016–2021 · Project on CORDIS ↗

  • NEWTBVACPartner

    Discovery and preclinical development of new generation tuberculosis vaccines

    FP7 (2007 to 2013) · 2010–2014 · Project on CORDIS ↗

  • ATPPartner

    Access to Pharmaceuticals

    FP7 (2007 to 2013) · 2009–2013 · Project on CORDIS ↗

    €160ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • RNA viruses
  • drug discovery
  • epidemics prevention
  • immunotherapy
  • infectious diseases
  • obstetrics
  • pathology
  • pharmaceutical drugs
  • primatology
  • public health
  • structural biology
  • toxicology
  • tropical medicine
  • tuberculosis

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime